In line with these results, one RB tumor investigated displayed unvaried high TFF1 secretion into the AH during therapy and developed a relapse after five months, possibly indicating persisting RB tumor cells not readily visible in funduscopy and sonography. Here, TFF1 is linked to neoplasm.